Please login to the form below

Not currently logged in
Email:
Password:

Arcoxia

This page shows the latest Arcoxia news and features for those working in and with pharma, biotech and healthcare.

Grunenthal to market MSD’s pain drug

Grunenthal to market MSD’s pain drug

In these countries, Grünenthal will hold exclusive promotion and distribution rights to the COX-2 inhibitor etoricoxib under the brand name Arcoxia. ... During this time Arcoxia has made a substantial amount of money for MSD - known as Merck &Co in the

Latest news

  • Icon Icon

    Hotfoot from seeing Madonna at the New York Superbowl, Stephanie Berman gives us some inspired thoughts on the power of branding - PMLiVE

  • New Accounts, April, 2009 - Advertising

    MSD  . Arcoxia . Arthritis . RFA Advertising . NAPP . New product . Oncology . RFA Advertising .

  • New Accounts, March, 2009 - Advertising

    MSD  . Arcoxia . Arthritis . RFA Advertising . NAPP  . Depocyte . Oncology. RFA Advertising .

  • New Accounts, February, 2009 - Advertising

    Merck Serono  . N/A . Corporate . Life Healthcare Communications  . MSD/ Schering-Plough  . Ezetrol . Cardiology . RFA Advertising . MSD. Singulair . Asthma . RFA Advertising . MSD  . Arcoxia . Arthritis . RFA Advertising . NAPP  .

  • Merck lambasted over semi-revelation

    Merck claimed that the product is the most widely prescribed traditional NSAID in the world', and hence was an appropriate comparator for Arcoxia. ... Also, people withdrawing due to oedema-related adverse effects was significantly higher than in

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics